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Editorial Comment 
Vulnerability to Ischemic 
Ventricular Arrhythmias in Left 
Ventricular Hypertrophy* 
HASAN GARAN, MD, FACC 
Boston, Massachusetts 
Left ventricular hypertrophy commonly accompanies coro- 
nary artery disease and represents an additional risk factor 
for ventricular arrhythmias and sudden cardiac death (l-3). 
Despite widespread clinical and epidemiologic concern for 
reducing cardiovascular risk associated with hypertension, 
little is known about the mechanisms whereby left ventric- 
ular hypertrophy, which develops secondary to systemic 
hypertension or aortic valve disease, may enhance suscep- 
tibility to ventricular arrhythmias and sudden cardiac death 
in ischemic heart disease. Several animal models (4-7) have 
been developed to investigate the hemodynamic and hor- 
monal changes and modulations in coronary vascular re- 
serve associated with left ventricular hypertrophy, but ex- 
perimental electrophysiologic data (8) that specifically 
address ischemia-related ventricular arrhythmias in the pres- 
ence of left ventricular hypertrophy have been sparse. 
Increased susceptibility to ventricular tacbyarrbytbmia in 
myocardial hypertrophy. Several factors may underlie the 
increased susceptibility to ventricular tachycardia and ven- 
tricular fibrillation in myocardial hypertrophy. First, on the 
cellular level, observations in isolated myocytes suggest that 
the basic electrophysiology of hypertrophied myocardial 
cells may be abnormal. Prolonged action potential configura- 
tion, decreased conduction velocity and lowered rest mem- 
brane potential all have been reported in myocytes harvested 
from experimentally hypertrophied hearts (9-11). On the 
tissue level, there is evidence for diminished subendocardial 
coronary vascular reserve and, under stress, subendocardial 
ischemia (6,7) due to a long-term increase in myocardial 
oxygen demand in left ventricular hypertrophy. These 
changes may further enhance the differences in conduction 
velocity and recovery of excitability between endocardium 
and epicardium. It is highly probable that such nonuniform 
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electrophysiologic variables that are already present in the 
hypertrophic heart compound the electrophysiologic de- 
rangements that rapidly develop during acute myocardial 
ischemia, thereby increasing vulnerability to reentry or other 
mechanisms of arrhythmogenesis. 
The present study. The study by Martins and coworkers 
(12) in this issue of the Journal is a timely attempt to 
investigate in a canine model of renal hypertension how the 
presence of prior myocardial hypertrophy alters the electro- 
physiology of acute myocardial ischemia resulting from left 
circumflex coronary occlusion. The authors show that con- 
duction delay from endocardium to epicardium in the isch- 
emit zone is enhanced by previously established hypertro- 
phy and further hypothesize that this finding is related to the 
increased incidence of electrically induced ventricular tachy- 
cardia when myocardial hypertrophy and myocardial isch- 
emia coexist. 
In addition to attempting to elucidate an important mech- 
anism that may underlie the arrhythmias, this study (12) 
serves to illustrate how little is known about the electrophys- 
iology and arrhythmology of the hypertrophic state. The 
authors investigate the mechanisms associated with electri- 
cally induced ventricular tachycardia, which occurs with a 
high incidence in this canine model. On the other hand, in 
the same model, the incidence of spontaneous ventricular 
fibrillation during coronary occlusion was identical (3 1%) in 
control dogs and those with hypertrophy. This important 
observation does not receive due attention in the study. 
Unfortunately, the number of animals studied is not large 
enough to rule out with certainty a possible modest differ- 
ence in incidence of spontaneous ventricular fibrillation 
between the two groups. Nevertheless, the fact remains that 
the marked difference in the incidence of induced ventricular 
tachycardia between the control and hypertrophic groups 
was not present in the case of spontaneous ventricular 
arrhythmias. This finding raises the possibility that, at least 
in this model, the mechanisms of spontaneous and induced 
ventricular arrhythmias may be different or that multiple 
mechanisms may be instrumental when myocardial hyper- 
trophy and ischemia coexist. This important question re- 
mains unresolved. 
Implications. Carefully conducted electrophysiologic in- 
vestigations in animal models, especially conscious animals, 
where myocardial hypertrophy and myocardial ischemia can 
be made to coexist by long-term instrumentation (S), will be 
essential for our understanding of the mechanisms underly- 
ing ventricular arrhythmias encountered commonly in pa- 
tients with coronary artery disease and left ventricular 
hypertrophy. Clinical guidelines for antiarrhythmic manage- 
ment in myocardial hypertrophy are not clearly established 
and may differ from those applicable to ischemic heart 
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disease in the absence of hypertrophy. When these two 
common states coexist, arrhythmias may be more complex 
than those in either state alone and multiple mechanisms 
may be responsible. Examining and dissecting these mech- 
anisms under controlled circumstances in animal models are 
the first basic steps in understanding arrhythmogenesis and 
in improving antiarrhythmic management in patients with 
ischemic and hypertensive heart disease. 
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